View in EDS PDF Full Text

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

Saved in:
Bibliographic Details
Title: Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Authors: Davies F; NYU Langone Health, New York, NY, USA. faith.davies@nyulangone.org., Rifkin R; Rocky Mountain Cancer Centers, Denver, CO, USA., Costello C; Moores Cancer Center, University of California, San Diego, CA, USA., Morgan G; NYU Langone Health, New York, NY, USA., Usmani S; Carolinas Healthcare System, Charlotte, NC, USA., Abonour R; Indiana University, Indianapolis, IN, USA., Palumbo A; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Romanus D; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Hajek R; University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Terpos E; University of Athens School of Medicine, Athens, Greece., Cherepanov D; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Stull DM; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Huang H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Leleu X; CHU la Miletrie, Poiters, France., Berdeja J; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA., Lee HC; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Thompson M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, WI, USA., Boccadoro M; Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy., Zonder J; Karmanos Cancer Institute, Detroit, MI, USA., Cook G; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Puig N; Salamanca University Hospital, Salamanca, Spain., Vela-Ojeda J; Hospital de Especialidades Centro Medico Nacional la Raza, Mexico City, Mexico., Farrelly E; Xcenda, Palm Harbor, FL, USA., Raju A; Xcenda, Palm Harbor, FL, USA., Blazer M; Xcenda, Palm Harbor, FL, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Source: Annals of hematology [Ann Hematol] 2021 Sep; Vol. 100 (9), pp. 2325-2337. Date of Electronic Publication: 2021 May 10.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33970288
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Davies+F%22">Davies F</searchLink>; NYU Langone Health, New York, NY, USA. faith.davies@nyulangone.org.<br /><searchLink fieldCode="AU" term="%22Rifkin+R%22">Rifkin R</searchLink>; Rocky Mountain Cancer Centers, Denver, CO, USA.<br /><searchLink fieldCode="AU" term="%22Costello+C%22">Costello C</searchLink>; Moores Cancer Center, University of California, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Usmani+S%22">Usmani S</searchLink>; Carolinas Healthcare System, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Abonour+R%22">Abonour R</searchLink>; Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Palumbo+A%22">Palumbo A</searchLink>; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Romanus+D%22">Romanus D</searchLink>; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hajek+R%22">Hajek R</searchLink>; University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; University of Athens School of Medicine, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Cherepanov+D%22">Cherepanov D</searchLink>; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stull+DM%22">Stull DM</searchLink>; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Huang+H%22">Huang H</searchLink>; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; CHU la Miletrie, Poiters, France.<br /><searchLink fieldCode="AU" term="%22Berdeja+J%22">Berdeja J</searchLink>; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Lee+HC%22">Lee HC</searchLink>; University of Texas, MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Thompson+M%22">Thompson M</searchLink>; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Boccadoro+M%22">Boccadoro M</searchLink>; Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Zonder+J%22">Zonder J</searchLink>; Karmanos Cancer Institute, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Puig+N%22">Puig N</searchLink>; Salamanca University Hospital, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Vela-Ojeda+J%22">Vela-Ojeda J</searchLink>; Hospital de Especialidades Centro Medico Nacional la Raza, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Farrelly+E%22">Farrelly E</searchLink>; Xcenda, Palm Harbor, FL, USA.<br /><searchLink fieldCode="AU" term="%22Raju+A%22">Raju A</searchLink>; Xcenda, Palm Harbor, FL, USA.<br /><searchLink fieldCode="AU" term="%22Blazer+M%22">Blazer M</searchLink>; Xcenda, Palm Harbor, FL, USA.<br /><searchLink fieldCode="AU" term="%22Chari+A%22">Chari A</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2021 Sep; Vol. 100 (9), pp. 2325-2337. <i>Date of Electronic Publication: </i>2021 May 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33970288
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-021-04534-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2325
    Titles:
      – TitleFull: Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Davies F
      – PersonEntity:
          Name:
            NameFull: Rifkin R
      – PersonEntity:
          Name:
            NameFull: Costello C
      – PersonEntity:
          Name:
            NameFull: Morgan G
      – PersonEntity:
          Name:
            NameFull: Usmani S
      – PersonEntity:
          Name:
            NameFull: Abonour R
      – PersonEntity:
          Name:
            NameFull: Palumbo A
      – PersonEntity:
          Name:
            NameFull: Romanus D
      – PersonEntity:
          Name:
            NameFull: Hajek R
      – PersonEntity:
          Name:
            NameFull: Terpos E
      – PersonEntity:
          Name:
            NameFull: Cherepanov D
      – PersonEntity:
          Name:
            NameFull: Stull DM
      – PersonEntity:
          Name:
            NameFull: Huang H
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Berdeja J
      – PersonEntity:
          Name:
            NameFull: Lee HC
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Thompson M
      – PersonEntity:
          Name:
            NameFull: Boccadoro M
      – PersonEntity:
          Name:
            NameFull: Zonder J
      – PersonEntity:
          Name:
            NameFull: Cook G
      – PersonEntity:
          Name:
            NameFull: Puig N
      – PersonEntity:
          Name:
            NameFull: Vela-Ojeda J
      – PersonEntity:
          Name:
            NameFull: Farrelly E
      – PersonEntity:
          Name:
            NameFull: Raju A
      – PersonEntity:
          Name:
            NameFull: Blazer M
      – PersonEntity:
          Name:
            NameFull: Chari A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 100
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1